Rani Therapeutics Expands its Collaboration with Celltrion to Develop Oral Version of Humira Biosimilar RT-105
Shots: The recent collaboration was based on the Celltrion's previous agreemen...
Dr. Reddy Reports the Completion of the P-I Study of DRL_TC, a Proposed Biosimilar of Tocilizumab for Rheumatoid Arthritis
Shots: The P-I study evaluating PK & PD of proposed tocilizumab biosimilar DRL...
Samsung Bioepis Receives EC’s Marketing Authorization for Epysqli (biosimilar, eculizumab) to Treat Paroxysmal Nocturnal Hemoglobi...
Shots: The EC has granted marketing authorization for Epysqli, a biosimilar refere...
Lupin Collaborated with Enzene Biosciences to Launch Cetuximab in India
Shots: The companies collaborated to launch Cetuximab, the first biosimilar develo...
Sandoz Reports the EMA Acceptance of MAA for Proposed Biosimilar Denosumab
Shots: The EMA has accepted the MAA for the proposed biosimilar denosumab (Prolia...
Celltrion’s Yuflyma (biosimilar, adalimumab) Receives the US FDA’s Approval for Multiple Indications
Shots: The US FDA has approved Yuflyma (adalimumab-aaty) as the ninth biosimilar r...
